Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy

Over the last decade, both early diagnosis and targeted therapy have improved the survival rates of many cancer patients. Most recently, immunotherapy has revolutionized the treatment options for cancers such as melanoma. Unfortunately, a significant portion of cancers (including lung and breast can...

Descripción completa

Detalles Bibliográficos
Autores principales: Soundararajan, Rama, Fradette, Jared J., Konen, Jessica M., Moulder, Stacy, Zhang, Xiang, Gibbons, Don L., Varadarajan, Navin, Wistuba, Ignacio I., Tripathy, Debasish, Bernatchez, Chantale, Byers, Lauren A., Chang, Jeffrey T., Contreras, Alejandro, Lim, Bora, Parra, Edwin Roger, Roarty, Emily B., Wang, Jing, Yang, Fei, Barton, Michelle, Rosen, Jeffrey M., Mani, Sendurai A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562947/
https://www.ncbi.nlm.nih.gov/pubmed/31137625
http://dx.doi.org/10.3390/cancers11050714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562947/
https://www.ncbi.nlm.nih.gov/pubmed/31137625
http://dx.doi.org/10.3390/cancers11050714

Ejemplares similares